Structural Heart Imaging Market Size, Share, Growth Report 2030

Structural Heart Imaging Market

Global Structural Heart Imaging Market By Imaging Modality (Echocardiogram and Angiogram), By Procedure Type (Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), Transcatheter Mitral Valve Repair (TMVR), Left Atrial Appendage Closure (LAAC), Annuloplasty, Valvuloplasty, and Others), By Application (Diagnosis and Surgery), By End-User (Hospitals, Specialty Clinics, Cardiac Centers, Diagnostic Centers, Ambulatory Surgical Centers, Catheterization Laboratories, and Others), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Category: Healthcare Report Format : PDF Pages: 288 Report Code: ZMR-6114 Published Date: Aug-2022 Status : Published

The global structural heart imaging market was valued at USD 13,275.10 million in 2021 and is predicted to reach USD 27,491.69 million by 2028, increasing at 12.90%.structural heart imaging Industry share By Imaging Modality, procedure type, Application, End-user, Region

Structural Heart Imaging Market

Structural Heart Imaging Market Size And Industry Analysis

The global structural heart imaging market size was worth USD 13,275.10 billion in 2021 and is estimated to grow to USD 27,491.69 billion by 2028, with a compound annual growth rate (CAGR) of approximately 12.90 percent over the forecast period. The report analyzes the structural heart imaging market’s drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the structural heart imaging market.

Global Structural Heart Imaging MarketRequest Free Sample

Structural Heart Imaging (SHI) Market: Overview

Structural heart imaging (SHI) is an imaging technique that uses a high-resolution camera to screen the heart to produce clear images that help doctors accurately diagnose a patient’s heart condition. Echocardiography and angiography (MRI, CT, etc.) are the most widely used structural imaging modalities to evaluate cardiac structure and identify narrowing or blockage of blood vessels. The key factors that are expected to drive the growth of the global structural heart imaging market during the forecast period are the increasing prevalence of cardiac heart disease (CHD) globally. In addition, increasing advances in imaging modality technology are expected to drive the growth of the structured heart imaging market. In addition, increasing knowledge about heart diseases, including high blood pressure, could reduce the development of the structured heart imaging (SHI) market.

On the other hand, rising costs are expected to hinder the growth of the structured heart imaging market during the forecast period. Furthermore, the increasing acceptance of advanced devices will present more potential opportunities for structural heart imaging market growth in the coming years. However, inadequate return policies may still challenge the development of the structured heart imaging (SHI) market in the near future.

Global Structural Heart Imaging MarketRequest Free Sample

To know more about this report, request a sample copy.

COVID-19 Impact:

The COVID-19 pandemic has impacted the businesses of structural heart imaging. The COVID-19 pandemic spread throughout the world as strict lock-downs are implemented by governments and shut down companies. Thus, the movement of people is restricted during the Covid-19 pandemic; the global structural heart imaging market is likely to be impacted considerably during the forecast period. Besides that, the limited use of these procedures affected the market growth during the pandemic period.

Key Insights

  • As per the analysis shared by our research analyst, the global structural heart imaging market value is expected to grow at a CAGR of 12.9% over the forecast period.
  • In terms of revenue, the global structural heart imaging market size was valued at USD 13,275.10 billion in 2021 and is estimated to grow to USD 27,491.69 billion by 2028.
  • The key factors that are expected to drive the growth of the global structural heart imaging market during the forecast period are the increasing prevalence of cardiac heart disease (CHD) globally.
  • By imaging modality, the angiogram segment dominated with accounted significant market share in 2021.
  • By procedure type, the transcatheter aortic valve replacement (TAVR) segment accounted significant amount of market share in 2021.
  • In 2021, the North American region dominated the market and accounted for the largest revenue share.

Structural Heart Imaging Market: Growth Drivers

The increasing prevalence of CHD aids the global market growth

The global structural heart imaging market is mainly driven by factors such as the increasing prevalence of cardiac heart disease (CHD) worldwide, the rising development in imaging modality technology, and growing awareness of heart diseases such as high blood pressure. According to an article published by the Centers for Disease Control and Prevention, in 2019, coronary heart disease affects about 1% of approximately 40,000 births annually, and about 100 to 200 deaths occur yearly due to undetected heart disease in infants in the USA. As a result, the demand for cardiac structural imaging is also increasing, contributing to the growth of the global market.

Structural Heart Imaging Market: Restraints

The strict regulatory guidelines may hamper the global market growth

The key restraints for the global structural heart imaging market are the stringent regulatory guidelines for equipment used in cardiac structural imaging, lack of awareness of cardiac-specific structural imaging, and higher cost are some of the factors the market is expected to hinder market growth.

Structural Heart Imaging Market: Opportunities

The technological advancement in structural heart imaging by market players brings up several growth opportunities

Structural intervention in heart disease is a revolutionary breakthrough that has replaced open surgery and enabled more patients to be treated at a reduced cost. Significant advances have been made in structural cardiac interventions over the past decade. Advances in procedure and imaging are closely linked, from transcardiac aortic and pulmonary valve replacement to left atrial appendage occlusion procedures and mitral repair techniques percutaneous and, more recently, mitral valve replacement with transcardiocentesis & tricuspid intervention.

For instance, the commercial availability of three-dimensional (3D) echocardiography has improved edge-to-edge repair techniques' efficiency, accuracy, and adaptability. The collaboration of ultrasound and equipment companies continues to produce breakthroughs in imaging that can contribute to devising innovation, partly to imaging groups such as the Ultrasonic Society. U.S. echocardiography. Because of the imaging-intensive nature of all these procedures, the radiographer must be familiar with many of the anatomical goals and modern imaging techniques and perform a variety of procedural interventions. Cameras have proven to be crucial to the continued advancement of the field because of this information base. Therefore, the market is expected to offer opportunities from the abovementioned factors during the forecast period.

Structural Heart Imaging Market: Challenges

  • The high cost of structural heart imaging is a global challenge: the high cost of installation and maintenance of structural heart imaging is a global challenge as it hinders the adoption of these types of equipment by hospitals and other end users.
  • The requirement of government certifications and permission is also a barrier for market players. It limits the use of these types of equipment in the healthcare industry as new market players face problems making their presence in the global market.

Structural Heart Imaging Market: Segmentation

The global structural heart imaging market is segregated based on imaging modality, procedure type, application, end-user, and region.

By imaging modality, the market is divided into echocardiograms and angiograms. Among these, the angiogram segment dominated in 2021. Growth of this segment is favored as demand for different imaging modalities is expected to increase due to the increased diagnostic demand and effective imaging for detecting SHD, especially CHD.

By procedure type, the market is bifurcated into transcatheter aortic valve replacement (TAVR), surgical aortic valve replacement (SAVR), transcatheter mitral valve repair (TMVR), left atrial appendage closure (LAAC), annuloplasty, valvuloplasty, and others. Over the forecast period, the transcatheter aortic valve replacement (TAVR) segment is expected to account for the largest share of revenue during the forecast period. The growth of this segment is mainly due to the increasing number of TAVR procedures being implemented worldwide, the durability and long-term effects of these products, and favorable regulatory policies for their use of these devices.

Recent Developments

  • October 2021 - NuVera Medical, Inc. published promising results from a non-randomized, single-center First-In-Human (FIH) study that investigated the feasibility of the NuVision ICE Catheter in visualizing the anatomical structures of patients undergoing surgical procedures. Structural heart procedures such as mitral or tricuspid valve repair or LAAC repair. The company is focusing on improving the effectiveness of catheter-based cardiac interventions through cutting-edge 4D ICE imaging.
  • November 2021 - Abbott has developed a minimally invasive valve repair device that can be used to treat mitral regurgitation. The product is considered an important treatment option for people with mitral regurgitation due to heart failure.

Report Scope:

Report Attributes Report Details
Report Name Structural Heart Imaging Market Size Report
Market Size in 2021 USD 13,275.10 million
Market Forecast in 2028 USD 27,491.69 million
Compound Annual Growth Rate CAGR of 12.90%
Number of Pages 288
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Abbott Laboratories, Circle Cardiovascular Imaging Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Koninklijke Philips N.V., Integer Holdings Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, LivaNova PLC, Siemens Healthcare GmbH, and Pie Medical Imaging B.V
Segments Covered By Type,By end-user, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Countries Covered North America: U.S and Canada
Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
Latin America: Brazil, Argentina, Chile
The Middle East And Africa: South Africa, GCC, Rest of MEA
Base Year 2021
Historical Year 2016 to 2020
Forecast Year 2022 - 2030
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Structural Heart Imaging Market: Regional Landscape

The growing number of patients and presence of market players help North America dominate the global market

In 2021, North America dominated the global structural heart imaging market with the highest market revenue share. The incidence of congenital heart defects is increasing; there is a growing need for enhanced technology to treat structural heart disease, increasing adoption of lifestyle changes, growing awareness of structural illnesses, more preventive care, favorable government policies, clinical trials and product introductions by significant players in the region are some of the factors that will drive market growth during the forecast period. For example, according to the Centers for Disease Control and Prevention, the most common congenital disabilities are congenital heart defects, and babies are born with these problems.

Coronary artery disease affects nearly 1% of births or about 40,000 births annually in the United States. Some coronary heart diseases, especially mild forms, are increasing in prevalence (number of babies born with heart defects divided by the total number of babies born). At the same time, rates for other types are unchanged. A ventricular septal defect (VSD) is the most common type of heart defect. 1 out of 4 newborns has acute coronary artery disease. Newborns with severe coronary heart disease often need surgery or other procedures during their first year. Therefore, the North American region is expected to hold the largest market share during the forecast period because of the abovementioned factors.

Structural Heart Imaging Market: Competitive Landscape

Some of the main competitors dominating the global structural heart imaging market include - Abbott Laboratories, Circle Cardiovascular Imaging Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Koninklijke Philips N.V., Integer Holdings Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, LivaNova PLC, Siemens Healthcare GmbH, and Pie Medical Imaging B.V.

The global structural heart imaging market is segmented as follows:

By Imaging Modality

  • Echocardiogram
  • Angiogram

By procedure type

  • Transcatheter Aortic Valve Replacement (TAVR) 
  • Surgical Aortic Valve Replacement (SAVR) 
  • Transcatheter Mitral Valve Repair (TMVR) 
  • Left Atrial Appendage Closure (LAAC)
  • Annuloplasty 
  • Valvuloplasty
  • Others

By Application

  • Diagnosis
  • Surgery

By End-user

  • Hospitals 
  • Specialty Clinics 
  • Cardiac Centers 
  • Diagnostic Centers 
  • Ambulatory Surgical Centers 
  • Catheterization Laboratories 
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

The global structural heart imaging market is mainly driven by factors such as the increasing prevalence of cardiac heart disease (CHD) worldwide, the growing development in imaging modality technology, and rising awareness of heart diseases such as high blood pressure. According to an article published by the Centers for Disease Control and Prevention, in 2019, coronary heart disease affects about 1% of approximately 40,000 births annually, and about 100 to 200 deaths occur yearly due to undetected heart disease in infants in the USA. As a result, the demand for cardiac structural imaging is also increasing, contributing to the growth of the global market.

According to a report, the global structural heart imaging market was worth 13,275.10 (USD billion) in 2021 and is predicted to grow to 27,491.69 (USD billion) by 2028, with a compound annual growth rate (CAGR) of about 12.90 percent.

North America has the highest share of the market revenue. The incidence of congenital heart defects is increasing; there is a growing need for technology to enhance technology to treat structural heart disease, increasing adoption of lifestyle changes, growing awareness of structural illnesses, etc. architecture, more preventive care, favorable government policies, clinical trials and product introductions by significant players in the region are some of the factors that make the market expected to grow in the forecast period.

Some of the main competitors dominating the global structural heart imaging market include Abbott Laboratories, Circle Cardiovascular Imaging Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Koninklijke Philips N.V., Integer Holdings Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, LivaNova PLC, Siemens Healthcare GmbH, and Pie Medical Imaging B.V.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed